Ocrevus (ocrelizumab): New risk of drug-induced liver injury and recommendations on monitoring of liver function before and during treatment
08/10/2026
Medicines for human use
Direct healthcare professional communication (DHPC)
Important Safety Information from Roche Products (Ireland) Limited regarding Ocrevus (ocrelizumab): New risk of drug-induced liver injury and recommendations on monitoring of liver function before and during treatment